Comparison of CO breath testing and women's self-reporting of smoking behaviour for identifying smoking during pregnancy by Usmani, Zara C et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Substance Abuse Treatment, 
Prevention, and Policy
Open Access Research
Comparison of CO breath testing and women's self-reporting of 
smoking behaviour for identifying smoking during pregnancy
Zara C Usmani*1, Pauline Craig2, Deborah Shipton3 and David Tappin1
Address: 1PEACH Unit, Department of Child Health, University of Glasgow, 8th Floor Tower, Queen Mother Hospital, Yorkhill, Glasgow, UK, 
2Glasgow Centre for Population Health, 39 St Vincent Place, Glasgow, UK and 3Social & Public Health Sciences Unit, Medical Research Council, 
Glasgow, UK
Email: Zara C Usmani* - zarausmani@hotmail.com; Pauline Craig - Pauline.Craig@glasgow.gov.uk; 
Deborah Shipton - deborah@sphsu.mrc.ac.uk; David Tappin - goda11@udcf.gla.ac.uk
* Corresponding author    
Abstract
Background: Healthcare services often use a carbon monoxide (CO) breath test to validate self-
reported smoking and to assess reductions in smoking habit. A cut-off level of ≥ 8 parts per million
(p.p.m.) is used to identify smoking. This cut-off requires further validation in pregnant women.
Methods: Data on self-reported smoking were assessed in conjunction with breath CO levels.
Subjects in the study were 2548 women attending antenatal booking during 12 months.
Results: 546/2584 (21.4%) women self-reported as current smokers. A cut-off of 8 ppm identified
only 325/546 self-reported smokers (sensitivity 59.4%). 27/2002 self-reported non-smokers had
levels greater than 8 ppm (specificity 98.7%). Sensitivity and specificity analysis revealed that CO
cut-off levels of 2 or 3 p.p.m. resulted in the best sensitivity and specificity for discriminating
apparent smokers and non-smokers. A cut-off of 2 p.p.m. would have identified 468/546 of self-
reported smokers (sensitivity 86%). 206/2002 self-reported non-smokers had levels > 2 ppm
(specificity 90 %). If all these women were 'true' smokers, the real prevalence of smoking in
pregnancy was 26.5% (752/2548) and 27% of true smokers provided false answers to the self-
reported question at maternity booking.
Conclusion: At 8 ppm, many smokers are missed and there may be gross underestimating of levels
of smoking in a pregnant population. Results emphasise the need to support a lower cut-off level
for the breath CO test closer to 2 or 3 p.p.m. These cut-offs may be more appropriate in the
antenatal clinic setting, and are in line with recent recommendations in the non-pregnant
population.
Background
Many studies have attempted to assess the effects of smok-
ing during pregnancy on maternal and child complica-
tions. Adverse consequences, including premature birth,
low birth weight and long-term sequelae including devel-
opmental problems such as cognitive delays have been
connected to maternal smoking [1,2].
A variety of factors have contributed to making it difficult
to evaluate the effects of smoking during pregnancy. These
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include errors in measurement such as maternal denial
and under-reporting, fluctuating behaviour of smoking
during pregnancy and metabolism, including accelerated
metabolism during pregnancy [3].
It is important clinically to have knowledge of patients
smoking habits since it enables appropriate anti-smoking
advice to be given and pregnancy is seen as a window of
opportunity to provide this. Meta-analyses, including a
Cochrane review, show that appropriate screening plus
active intervention, in the form of advice and provision of
written materials, increases the numbers of pregnant
women who stop smoking. This in turn can reverse the
adverse effects of smoking on perinatal outcomes by up to
20% [4,5]. It has also been emphasised that, in pregnancy,
biochemical validation can increase women's motivation
to stop smoking and increase their utilization of available
treatment services [6], though a recent review showed no
evidence that biofeedback motivated cessation [7].
In the general population, the proportion of people who
report to be non-smokers but show biochemical levels
indicative of smoking are generally low [8]. In pregnancy,
however, women who smoke can experience intense
social and clinical pressure that results in false declara-
tions of non-smoking. This inaccuracy of self-reported
smoking makes appropriate counselling difficult and
stresses the need for reliable biochemical confirmation of
smoking status [9].
Of the biochemical measures to assess smoking, cotinine,
a metabolite of nicotine found in the blood and urine, is
most preferred by scientists because of its long half-life,
averaging 17 hr in non-pregnant women [10] and 9 hr in
pregnant women [11]. In the clinical setting however,
breath carbon monoxide (CO) level is seen to provide an
immediate, non-invasive method of assessing smoking
status and is the method most suitable to the antenatal
clinic [12]. It is less preferred as a biochemical marker
because CO has a short half-life of approximately 1–4
hours [13] and may not detect low levels of smoking [14].
Furthermore, the development of relatively inexpensive
portable CO monitors enables breath CO levels to be
assessed in a wide variety of clinical settings [15].
Currently in Glasgow, all women attending the antenatal
clinic are CO monitored and those with a reading of ≥ 8
ppm or self-reported smokers are directly referred to a
smoking cessation link midwife for a 6 week support pro-
gramme. Since the results of the CO test and or self-report
are the critical factors for referral for cessation advice, the
accuracy of these is paramount to providing intervention.
The 8 ppm cut-off in this programme is based on a stand-
ard cut-off for abstinence verification that is widely
accepted within the research community [16]. New evi-
dence suggests that this may not be appropriate in all set-
tings. Recently, Javors et al concluded that the cut-off
should be lowered to 2 or 3 ppm for assessment of smok-
ing in a general population and a cut-off of 4 ppm in post
partum women was suggested [17,18].
The present study examines the sensitivity and specificity
of the breath CO test, and the optimal cut-off level to dis-
tinguish smokers from non-smokers amongst pregnant
women.
Methods
Data was collected at the antenatal booking appointment
when women have a form completed by a nursing auxil-
iary along with the results of a CO breath test. These forms
were obtained from the office for the Scottish smoking
intervention programme called 'Breathe', in the Southern
General Maternity Unit, Glasgow. Ethical approval was
obtained from the Local Research Ethics Committee.
The Southern General Hospital has an 85–90% rate of
return for the Breathe service forms of all women booked;
the results of the present report are therefore likely to be
applicable to the general pregnant population. Women
who provided relevant Breathe forms and booked for
antenatal care in the Southern General Hospital Glasgow
between the months of July 2005 and June 2006 were
included in this study.
The cut-off level for a CO test indicates that a result at or
above (≥) the cut-off level would be a positive test for a
smoking day (presumed to have smoked). A CO level
below the cut-off would be a negative test (presumed a
non smoker). In this study, various CO cut-off levels were
used to evaluate cut-off levels for their accuracy in identi-
fying pregnant smokers and non smokers. For example,
CO level of 3 p.p.m. would be a positive test at a CO cut-
off of 3 p.p.m.
Study Procedure
All Breathe forms for women who booked between the
months of July 2005 and June 2006 were inspected. Data
on these forms is recorded by a midwife or auxiliary nurse
at the antenatal booking clinic. At the clinic, the CO test is
offered at a point suited to the midwife/auxiliary nurse
and the test itself is performed using the EC50 Smoker-
lyzer (Bedfont Instruments; Kent, UK), an inexpensive,
portable CO monitor that has previously been shown to
be effective [15]. Midwives and auxiliary nurses have a
two hour accredited training session regarding use of the
device.
Data extracted from the forms included: self-reported
smoking status, CO levels measured at the booking visit,
date of birth, date of booking, number of cigarettesSubstance Abuse Treatment, Prevention, and Policy 2008, 3:4 http://www.substanceabusepolicy.com/content/3/1/4
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smoked per day and any additional comments made by
the women.
Statistical methods
Self-reported smoking and CO validated smoking status
were analysed descriptively, using sensitivity and specifi-
city percentages. Sensitivity was defined as the percentage
of positive CO tests (a CO level at or above a given cut-off)
for self-reported smokers, i.e. the percentage of all self-
reported smokers for which there was a positive CO test.
Specificity was defined as the percentage of negative CO
tests (a CO level below a given cut-off) for self-reported
non-smokers, i.e. percentage of all non-smokers for which
there was a negative CO test. (Sensitivity + specificity)
divided by 2 was calculated for each possible cut-off to
identify the CO cut-off level that would have the highest
average of combined sensitivity plus specificity.
Data were analysed by the SPSS 14 and Minitab 14 statis-
tical packages.
Results
Levels of smoking, and sensitivity, specificity of self-report 
against carbon monoxide (CO)
Of the 2661 women in the 'Breathe' dataset 2650 (99.6%)
had self reported smoking data and 2548 (95.8%) had
both self reported smoking data and CO validated meas-
urements. Of these 2548 women, n = 2002 (78.6%)
reported they were non-smokers and n = 546 (21.4%)
were current smokers. 13.9% (n = 354) of women had a
CO level of = 8 p.p.m. and were categorised by the current
cut-off as validated smokers. The CO breath test results
and self reported smoking status for all subjects are shown
(Table 1, Figure 1).
Twenty-seven women with a CO of ≥ 8 p.p.m. described
themselves as non-smokers (98.7% specificity); whereas
219 women with CO levels < 8 ppm reported they were
smokers (59.4% sensitivity). Median CO level was 1
p.p.m. for non-smokers and 10 p.p.m. for smokers.
Alternative Carbon Monoxide cut-off levels
As the CO cut-off increased in value from 1 to 12 p.p.m.,
sensitivity decreased and specificity increased (Table 2).
The highest average for combined sensitivity and specifi-
Bar Chart of CO measurements for non-smokers and smok- ers Figure 1
Bar Chart of CO measurements for non-smokers 
and smokers. The four lines indicate a) and b) 2 and 3 
p.p.m.: the cut-off points with highest sensitivity and specifi-
city c) 5 ppm: the new cut off for the Breathe programme 
and d) 8 ppm: the current cut-off point. It is possible to visu-
alise the increase in number of subjects picked up by the test 
as the cut-off point is lowered. Note: The scale for the fre-
quency of women has been truncated so as to remove the 
large peak of non-smokers at 1 p.p.m. (n = 1790). This allows 
the results for all women to be visualized more appropri-
ately.
d)
c)
b)
a)
Table 1: CO breath test result and self reported smoking status for all subjects
CO breath test CO level Non smokers 
(number)
Smokers (number) Total number
0–10 11–20 21–30 >30
0600006
1 1790 70 6 0 0 1866
26 6 1 14 0 08 1
35 9 2 64 0 08 9
42 8 2 32 1 05 4
51 7 1 59 0 04 1
64 2 0 210 2 7
75 1 4 830 3 0
≥82 7 1 7 7 1 1 4 3 0 63 5 4
Total 2002 2548Substance Abuse Treatment, Prevention, and Policy 2008, 3:4 http://www.substanceabusepolicy.com/content/3/1/4
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city (88%) was observed at a CO cut-off level of 2 and 3
p.p.m. When plotted (Figure 2), the sensitivity and specif-
icity curves intersect at a CO level between 2 and 3 p.p.m.
This intersection indicates that the highest combined sen-
sitivity and specificity was observed at a CO cut-off level
less than 3 p.p.m.
At a CO cut-off level of 2 p.p.m, 1796 of the 2002 non-
smokers had negative tests (specificity = 90 %), whereas
468 of 546 smokers had positive tests (sensitivity = 86%).
This contrasts sharply with a CO cut-off level of 8 p.p.m.
where, 1975 of 2002 non-smokers had negative tests (spe-
cificity = 99%), but only 327 of 546 smokers had positive
tests (sensitivity = 60%).
Relationship between cigarettes smoked per day and CO 
levels
The mean CO levels increase with increasing number of
reported cigarettes smoked (Figure 3). The maximum and
minimum CO values illustrate the overlap for CO levels
between the categories for numbers of cigarettes smoked.
Discussion
The current paper examines the relationship between self-
reported smoking status and validated smoking status
using the Carbon Monoxide (CO) breath test. Results
show that, with a sensitivity of 60%, the cut-off level of 8
ppm used for CO tests in the antenatal booking clinic is
insufficiently sensitive. Of the 546 women who reported
to be smokers 219 had CO values <8 ppm. Other than the
possibility of data input error by midwives and nurses,
there i, s no reason to presume women would say they
smoke when they do not. It seems likely, therefore, that
their smoking levels were too low to be detected and that
the cut-off point for the CO test to improve detection of
smokers requires adjusting downwards. This is especially
important as light smokers are more likely to respond to
smoking cessation intervention. It is important to recog-
nise that breath CO has a short half-life of approximately
1–4 hours and thus it may not detect low levels of smok-
ing [14]. In this study, the lower level of cigarette smoking
Mean CO levels for each cigarette category with 95% confi- dence intervals for all reported smokers (N = 546) Figure 3
Mean CO levels for each cigarette category with 95% 
confidence intervals for all reported smokers (N = 
546). The mean CO value for all smokers in each category is 
shown above the bar. The minimum and maximum CO levels 
for those smoking <10, 11–20, 21–30 and 30+ cigarettes are, 
1–34, 1–35, 4–37 and 13–36 p.p.m. respectively.
greater than 30 21-30 11-20 10 or less
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Sensitivity and specificity curves Figure 2
Sensitivity and specificity curves. CO cut-off levels from 
1 to 9 p.p.m. were plotted. Definitions for sensitivity and spe-
cificity can be found in the Methods.
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Table 2: Sensitivity and specificity of various CO cut-off levels
CO cut-off 
(p.p.m.)
Sensitivity Specificty (Sensitivity + 
specificity)/2
0 10 0 . 5
1 1 0.2 0.6
2 0.857 0.897 0.88
3 0.832 0.930 0.88
4 0.777 0.960 0.87
5 0.729 0.974 0.85
6 0.685 0.982 0.83
7 0.643 0.984 0.81
8 0.594 0.987 0.79
9 0.559 0.989 0.77
10 0.502 0.990 0.75
11 0.465 0.992 0.73
12 0.408 0.995 0.70Substance Abuse Treatment, Prevention, and Policy 2008, 3:4 http://www.substanceabusepolicy.com/content/3/1/4
Page 5 of 7
(page number not for citation purposes)
in women who did not reach a cut-off of 8 ppm reflects
this.
Evaluation of alternative cut-off levels pointed to a CO
cut-off of 2 or 3 p.p.m. providing the highest accuracy for
assessment of abstinence of smoking in this population.
This cut-off was confirmed by several analyses. When the
cut-off level was lowered, the sensitivity and specificity for
self-reported smoking against CO, at 86% and 90% for 2
p.p.m. and 83% and 93% for 3 p.p.m., respectively, were
high. This contrasts to the lower average of combined sen-
sitivity and specificity observed at a cut-off of 8 ppm.
Javors et al [17] recently suggested that a cut-off of 2 to 3
p.p.m. is more appropriate for detecting smokers within
the general population. The current paper concurs with
cut-off levels of 2 ppm and 3 ppm in the antenatal clinic
setting to detect, with reasonable accuracy and discrimina-
tion, women who are smokers.
Accuracy of self reported smoking
There is a caveat with regard to the use of self reported
smoking to establish the CO cut-off. In Scotland the pro-
portion of pregnant women smoking at booking is
approximately 25% and in Glasgow this figure is even
higher at 31.2% [19]. The proportion of self reported
smokers in the current study population was 21% indicat-
ing that at least 10% of women in this population are
potentially not telling the truth about their smoking sta-
tus. This inaccuracy in reporting could explain why many
reported non-smokers had CO levels beyond 2–3 p.p.m.
and why 27 reported non-smokers had readings ≥ 8
p.p.m. There were some interesting comments made by
women who reported as non-smokers but who had high
CO levels:
￿ "..sitting in front of a smoker on the bus here" (24 ppm)
￿ "Gas fire needs fixing" (13 ppm)
￿ "Walked under the bridge on the way here – a lot of pol-
lution" (9 ppm)
There are suggestions that changes in pregnancy may
increase CO absorption from non-smoking sources, par-
ticularly later in pregnancy [20]. However, the contribu-
tion of environmental smoke exposure is multifactorial
and difficult to assess: the reported cause is unlikely to be
a sound measure of exposure. At such high levels one can
almost be certain these women are denying their smoking
status and that reporting exposure to environmental
sources may have offered a "way out" for some women
who did not want to admit to smoking. The Information
Services Division for Scotland (ISD) states that the data on
smoking behaviour are: "...based on self-reported infor-
mation obtained from mothers at their ante-natal book-
ing visit in the community or at hospital." The lower
prevalence of smoking found in this study population
may indicate that self reported smoking is not accurate in
the antenatal clinic setting. Since the ISD use self reported
smoking at the antenatal booking clinic to quantify the
number of pregnant smokers, they are potentially under-
estimating levels of smoking in the Scottish population.
Thus, self reported smoking is an imperfect method of
recording smoking status in this population.
CO p.p.m. versus self reported intensity of smoking levels
There is considerable overlap in CO levels for all catego-
ries of number of cigarettes smoked. For example, a
woman smoking 21–30 cigarettes could have the same
reading, as low as 4 ppm, as a woman smoking 10 or
fewer cigarettes. Time since last cigarette and CO testing
and also underreporting of number of cigarettes smoked
requires further study with direct measures such as coti-
nine to support findings in this study that the CO test is
poor at distinguishing between different intensities of cig-
arette smoking. Since the CO means are noticeably differ-
ent for the various smoking categories the CO test may be
useful for showing only major changes in reduction of cig-
arette intake, and this could be used as a motivational
tool.
It is recognised in current literature that light smokers
(women smoking less than 10 cigarettes per day) are sig-
nificantly more likely to quit during pregnancy [21]. It is
therefore essential that any screening programme identi-
fying smokers must pick up with accuracy, this population
of pregnant smokers.
Policy Issues
It has been documented in studies in New Zealand and
the US that at maternity booking or at the end of preg-
nancy, over 20% of pregnant smokers falsely categorise
themselves as non-smokers when asked by their midwife.
This is the method used in the UK to identify pregnant
smokers in order to refer them for specialist smoking ces-
sation support. [22]
The under-reporting is likely to result from fear of disap-
proval rather than because these women don't want to
stop smoking. There is a recognised policy in the UK to
establish services for pregnant smokers. If the identifica-
tion system (self-report at maternity booking) misses out
20% of pregnant smokers, by not recognising them, they
are denied an important service. It is therefore important
to identify their smoking habit in a less judgmental fash-
ion: perhaps in the same way that all women in the UK are
screened at maternity booking for syphilis by testing their
blood samples. Our study shows that CO breath testing at
the recognised cut-off does not accurately detect smokers,
particularly low level pregnant smokers who are a targetSubstance Abuse Treatment, Prevention, and Policy 2008, 3:4 http://www.substanceabusepolicy.com/content/3/1/4
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group. Another biochemical marker such as cotinine in
blood or urine may be required to identify all pregnant
smokers so they can benefit from specialist smoking ces-
sation support and to assess the effectiveness of interven-
tions. The role of clinicians is not necessarily to ensure the
success of making all smokers quit, but rather to provide
a reliable cessation service that is offered to all those who
smoke. Increasingly, smoking cessation services are using
the CO breath test for verification of non-smoking. The
Breathe Tobacco Planning Interest Group state that the
importance of the CO test is in its ability to demonstrate
an immediate and potentially harmful consequence of
smoking, and, consequently, to increase the number who
take part in the programme and comply with advice to
quit. By missing a large proportion of smokers, the test
does not achieve this effectively. As a consequence of the
current research the Planning Group have changed policy
in antenatal clinics and reduced the CO cut off point to ≥
5 ppm. This cut-off was seen as most appropriate when
balanced with available resources and in future may be
reduced further.
Limitations
It was not possible to control for the issue of time since
last cigarette and as a result it is possible that a woman
who smokes prior to the clinic will have a very different
CO reading to a woman who smokes after the clinic. It is
also possible that women who self reported as non-smok-
ers may have been light smokers, and may not have
exceeded a CO level of 2 or 3 ppm; thereby reducing fur-
ther the correlation between self report and biochemical
measures. Lower CO levels observed during pregnancy do
not necessarily reflect less smoke exposure, and cut-off
levels used to classify non-smokers, passive smokers, and
active smokers need to be established for pregnancy. It can
be expected that the quality of measurement performed
by midwives is variable. A further limitation was the use
of participant self-report as the "gold standard" to deter-
mine smoking status. Cotinine or thiocyanate are possible
alternative biomarkers of smoking for future study.
Conclusion
At a cut-off of 3 ppm 113 (4.4%) more women would
have been offered smoking cessation advice. The conse-
quences of referring non-smokers depend on the number
wrongly being referred. At 3 ppm a total of 113 of self-
reported "non-smokers" will be contacted. Midwives in
the service state that this is not a problem as most women
will state this when contacted and no further contact will
be made by the midwife. The impact on finances and
resources is an issue. To accurately assess this it would be
necessary to consider the number of women wrongly
being referred versus the long term benefits of contacting
a denier who then proceeds to use the service and quit.
The costs of contacting all women, "a blanket referral",
would most certainly outweigh the costs of carrying out a
CO test and therefore an appropriate cut-off is important
to maximise cost-benefit outcomes.
At 8 p.p.m., many smokers are missed and there may be
gross underestimating of levels of smoking in a pregnant
population. Results emphasise the need for further
research to support a lower cut-off level for the breath CO
test closer to 2 or 3 p.p.m. This may be more appropriate
in the antenatal clinic setting, and is in line with recent
recommendation in the non-pregnant population.
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